Erratum: Survey of familial glioma and role of germline p16 INK4A/p14ARF and p53 mutation (Familial Cancer DOI: 10.1007/s10689-010-9346-5);Survey of familial glioma and role of germline p16INK4A/p14 ARF and p53 mutation

Familial Cancer

Volumn 9, Issue 3, 2010, Pages 413-421

  Robertson, Lindsay B ^a   Armstrong, Georgina N ^b   Olver, Bianca D ^a   Lloyd, Amy L ^a   Shete, Sanjay ^b   Lau, Ching ^c   Claus, Elizabeth B ^d,e   Barnholtz Sloan, Jill ^f   Lai, Rose ^g   Il'yasova, Dora ^h   Schildkraut, Joellen ^h   Bernstein, Jonine L ⁱ   Olson, Sara H ⁱ   Jenkins, Robert B ^j   Yang, Ping ^j   Rynerason, Amanda L ^j   Wrensch, Margaret ^k   McCoy, Lucie ^k   Wienkce, John K ^k   McCarthy, Bridget ^l   Davis, Faith ^l   Vick, Nicholas A ^m   Johansenxs, Christoffer ⁿ   Bødtcher, Hanne ⁿ   Sadetzki, Siegal ^o   Bruchim, Revital Bar Sade ^p   Yechezkel, Galit Hirsh ^q   Andersson, Ulrika ^r   Melin, Beatrice S ^r   Bondy, Melissa L ^b   Houlston, Richard S ^a   more..

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Och Spine at New York Presbyterian Hospitals   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁱ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^j MAYO CLINIC   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^m NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

ⁿ INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^o GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^p TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^q TEL AVIV UNIVERSITY   (Israel)

^r UMEÅ UNIVERSITY   (Sweden)

more..

Author keywords

Familial glioma; Mutation; P16INK4A p14ARF; P53

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN P53;

ADULT; AGED; ARTICLE; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GLIOBLASTOMA; GLIOMA; HISTOLOGY; HUMAN; LIBRARY SCIENCE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL;

EID: 78650223581     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-010-9353-6     Document Type: Erratum

References (17)

1. Bondy ML et al (2008) Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium. Cancer 113(7):1953-1968
2. Hemminki K et al (2009) Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. Lancet Oncol 10(5):481-488
3. Kyritsis AP et al (1994) Germline p53 gene mutations in subsets of glioma patients. J Natl Cancer Inst 86(5):344-349
4. Li YJ et al (1995) Incidence of germ-line p53 mutations in patients with gliomas. Int J Cancer 64(6):383-387
5. Tachibana I et al (2000) Investigation of germline PTEN, p53, p16 (INK4A)/p14 (ARF), and CDK4 alterations in familial glioma. Am J Med Genet 92(2):136-141
6. Gao L et al (1997) Lack of germ-line mutations of CDK4, p16 (INK4A), and p15 (INK4B) in families with glioma. Clin Cancer Res 3(6):977-981
7. Paunu N et al (2001) Analysis of p53 tumor suppressor gene in families with multiple glioma patients. J Neurooncol 55(3):159-165
8. Malmer B et al (2001) Microsatellite instability, PTEN and p53 germline mutations in glioma families. Acta Oncol 40(5):633-637
9. Malmer B et al (2007) GLIOGENE an international consortium to understand familial glioma. Cancer Epidemiol Biomarkers Prev 16(9):1730-1734
10. Yan H et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360(8):765-773
11. Varley JM et al (1999) Are there low-penetrance TP53 Alleles? Evidence from childhood adrenocortical tumors. Am J Hum Genet 65(4):995-1006
12. Randerson-Moor JA et al (2001) A germline deletion of p14 (ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum Mol Genet 10(1):55-62
13. Bahuau M et al (1998) Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res 58(11):2298-2303
14. Scheurer ME et al (2007) Aggregation of cancer in first-degree relatives of patients with glioma. Cancer Epidemiol Biomarkers Prev 16(11):2491-2495
15. Goldgar de et al (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86(21):1600-1608
16. Shete S et al (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41(8):899-904
17. Wrensch M et al (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41(8):905-908